Pieris Pharmaceuticals EBITDA Margin 1970-1969 | PVLA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pieris Pharmaceuticals (PVLA) over the last 10 years. The current EBITDA margin for Pieris Pharmaceuticals as of December 31, 1969 is .
| Pieris Pharmaceuticals EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
